Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fispemifene in hypogonadal men with ED unresponsive to PDE5 inhibitors
NCT00415571Phase 2Completed
- Sponsor
- QuatRx Pharmaceuticals
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fispemifene in erectile dysfunction (ED), Hypogonadism, sponsored by QuatRx Pharmaceuticals. Started Dec 2006; status: completed.
02
Drugs
fispemifene
03
Conditions
erectile dysfunction (ED)Hypogonadism
Beyond the preview
Go deeper on NCT00415571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415571.